House Bills
Share |

House Bill Updates

Click on the House Bill to see a summary of the bill.  

HB100 | Provides for Full-Practice Authority to Nurse Practitioners

HB353 | Electronic Prescription for Schedule II-V Control Substances

HB789 | Anesthesia Care in Hospital Setting | Former HB 1277

HB 1233 | To Change "Clear and Present Danger" Standard for Outpatient Commitment of Persons with Serious Mental Illness to a New Standard | Former HB 2423, 2015-2016 Session

HB1613 | Modernize Health Care Cost Containment Council | A Nurse added to Council by PA State Nurses Association

HB1987 | Dispensing of Fentanyl - Restricted Use

HB2201 | Opioid Reform Package: Mandating Prescribing Guidelines for Controlled Substances

HB2431 | Opioid Treatment Agreements

 

HB 100 | 2017-2018 Session | Topper, Jesse (R) | Provides for Full-Practice Authority to Nurse Practitioners | Former HB 765, 2015-2016 Session
Summary: HB 100 would amend The Professional Nursing Law. HB 100 would permit full-practice authority for a certified nurse practitioner or advanced practice registered nurse-certified nurse practitioner to practice as a licensed independent practitioner within scope of practice of specific clinical specialty area or population focus where nurse is certified and licensed by Board. HB 100 would require as additional qualifications that the nurse practitioner be in collaboration with a physician via a collaboration agreement or written agreement for a period of not less than three (3) years and not less than 3600 hours. Currently, 22 states and the District of Columbia allow nurse practitioners to have full practice authority. HB 100 was referred to the House Professional Licensure Committee on March 21, 2017. Press conference held on April 17-18, 2018. Link to Representative Topper’s Re-introduction of the Modernization of the Professional Nursing Law - CRNP Memorandum.

 

HB 353 | 2017-2018 Session | Nesbit, Ted (R) | Electronic Prescription for Schedule II-V Control Substances
Summary: HB 353 would amend the PA Controlled Substance, Drug, Device & Cosmetic Act to require that prescriptions for schedule II-IV controlled substances to be transmitted electronically with certain restrictions. HB 353 provides for exemptions to the electronic prescription requirement. See link to Representative Nesbit’s Electronic Prescription Requirements for Controlled Substances Memorandum. Referred to House Health Committee on February 6, 2017. Reported as amended, first consideration and re-committee to the House Rules Committee on June 6, 2017. Re-reported as committed, second consideration with amendments and re-committed to House Appropriations Committee on June 19, 2017. See remarks in House Journal Page 1076 for June 19, 2017. Re-reported as committed, third consideration and final passage on June 20, 2017 (194-0). Referred to Senate Health and Human Services Committee on June 23, 2017. Reported as amended and first consideration on June 20, 2018. Second consideration and re-referred to Senate Appropriations Committee on June 21, 2018. Re-reported as committed on September 24, 2018. Third consideration and final passage on October 16, 2018 (49-0). Referred to House Rules Committee and re-reported on concurrence, as committed on October 17, 2018. House concurred in Senate amendments on October 7, 2018 (187-0). For remarks, see House Journal Page ____, for October 17, 2018. Signed in House on October 17, 2018. Signed in Senate on October 17, 2018. Presented to Governor on October 17, 2018.

 

HB 789 | 2017-2018 Session | Christiana, Jim (R) | Anesthesia Care in Hospital Setting | Former HB 1277
Summary: HB 789 would amend the Medical Practice Act of 1985. The purpose of the bill is to provide provisions for the supervision of anesthesia care in a hospital setting. HB 789 was referred to the House Professional Licensure Committee on March 10, 2017. HB 789 is intended to put a requirement by regulation (28 Pa. Code § 123.5) into statute, i.e., to require physician supervision of the administration of anesthesia in a hospital setting. At this time, the supervision of anesthesia care in a hospital setting is not in the Medical Practice Act of 1985 or in its corresponding regulations. Referred to House Professional Licensure Committee on March 10, 2017.

 

HB 1233 | 2017-2018 Session | Murt, Thomas (R) | To Change “Clear and Present Danger” Standard for Outpatient Commitment of Persons with Serious Mental Illness to a New Standard | Former HB 2423, 2015-2016 Session
Summary: HB 1233 would amend the Mental Health Procedures Act. In Pennsylvania, the “clear and present danger” standard for those with a serious mental illness applies to both involuntary hospitalizations and outpatient treatment. HB 1233 would provide for a more reasonable standard for the Court to order outpatient treatment for a person with a serious mental illness. Forty-six (46) states have a different standard for court-ordered outpatient treatment. HB 1233 was referred to the House Human Services Committee on April 17, 2017. Second consideration, with amendments, occurred on June 20, 2017. HB 1233 passed on June 21, 2017 (189-0). HB 1233 was referred to the Senate Health and Human Services Committee on June 22, 2017. On March 20, 2018, the Senate Health and Human Services Committee had a meeting on HB 1233, which was reported as amended, with all twelve members of the committee voting in support of HB 1233. Senate first consideration on March 20, 2018. Laid on table on May 21, 2018. Link to Representative Murt’s A Better Standard for Outpatient Commitment for Persons with Serious Mental Illness Memorandum. Removed from table on October 2, 2018. Second consideration, with amendments and re-referred to HB1233 on October 15, 2018. Re-reported as committed on October 16, 2018. Third consideration and final passage on October 17, 2018. (49-0). Referred to House Rules Committee on October 17, 2018. Re-reported on concurrence, as committee and House concurred in Senate amendments on October 17, 2018 (181-0). Signed in House on October 17, 2018. Signed in senate on October 17, 2018. Presented to Governor on October 18, 2018.

 

HB 1613 | 2017-2018 Session | Cutler, Bryan (R) | Modernize Health Care Cost Containment Council | A Nurse added to Council by PA State Nurses Association
Summary: HB 1613 would amend Title 35 (Health and Safety) providing for an additional chapter, Chapter 33 (health Care Cost Containment) and providing for a Health Care Cost Containment Council, for its powers and duties, for health care cost containment through the collection and dissemination of data, for public accountability of health care costs and for health care for the indigent. The definition of "Provider" does not include a nurse practitioner. Additionally, under proposed section 3303, Health Care Cost Containment Council, the composition of the council would only include one nurse under section 3303(b)(8.2) “One representative of nurses, appointed by the Governor from a list of three qualified representatives recommended by the Pennsylvania State Nurses Association.” Therefore, as HB 1613 is currently written, a nurse practitioner from the PCNP would not be considered to be a part of the Council unless they were recommended by the PA State Nurses Association. Link to Representative Cutler’s Reauthorizing and Modernizing Pennsylvania Health Care Cost Containment Council Memorandum. Referred to House Health Committee on June 23, 2017. Reported as amended, first consideration and laid on table on September 13, 2017. See Remarks in House Journal Page 1535-1536 for September 26, 2017. Second consideration and re-committed to House Appropriations on October 2, 2017. See Remarks in House Journal Page 1559-1560 for October 2, 2017. Re-reported as committed, third consideration and final passage on October 3, 2017 (193-0). Referred to Senate Health and Human services Committee on October 5, 2017. In Senate, reported as amended and first consideration on June 21, 2018. Second consideration in Senate on June 22, 2018. Re-referred to Senate Appropriations on June 22, 2018. Re-reported as committed on September 24, 2018.

 

HB 1987 | 2017-2018 Session |Barbin, Bryan (D) | Dispensing of Fentanyl – Restricted Use
Summary: Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for dispensing of fentanyl to be limited to patient treated on an in-patient basis, remains under observation or during surgery; palliative or hospice care; management of pain associated with cancer; patient whose treatment is associated with a medical emergency as documented in individual’s medical record. Referred to the House Health Committee on December 22, 2017. Reported as amended by providing additional areas of use, first consideration, and laid on table on May 22, 2018. On May 24, 2018, HB 1987 was removed from the table. Second consideration with amendments and re-committed to House Appropriations Committee on June 12, 2018. For remarks, see House Journal for June 12, 2018. Re-reported as committed and third consideration with final passage on June 13, 2018 (191-0). See remarks in House Journal for June 13, 2018. Referred to the Senate Health and Human Services Committee on June 15, 2018. Link to Representative Barbin’s Fentanyl Limited Use Legislation Memorandum.

 

HB 2201 | 2017-2018 Session | Ortitay, Jason (R) | Opioid Reform Package: Mandating Prescribing Guidelines for Controlled Substances
Summary: HB 2201 would amend The Controlled Substance, Drug, Device and Cosmetic Act, by providing that the Department of Health should draft regulations for the prescribing of opioids in the following practice areas: (1) Pediatrics and adolescents; (2) Orthopedics and sports medicine; (3) Acute anxiety and insomnia; (4) Pregnant patients who have an opioid addiction; (5) Geriatric patients; (6) Dental patients; (7) Emergency patients; (8) Patients with chronic non-cancer pain; and, (9) Any other patient who is prescribed an opioid. HB 2201 would also provide for penalties on a prescriber for a violation of the regulations: (1) For a first violation, five hundred dollars ($500); (2) For a second violation, one thousand five hundred dollars ($1,500); (3) For a third violation, three thousand dollars ($3,000); and (4) For a fourth violation, the department shall notify the prescriber's licensure board of the violation and the licensure board shall revoke the prescriber's license. HB 2201 also provides that the term "prescriber" shall have the same meaning as provided in section 3 of the act of October 27, 2014 (P.L.2911, No.191), known as the "Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act." Referred to the Department of Human Services on April 2, 2018. HB 2201 was not addressed since June 9, 2018, but it is a companion bill to HB 2200, so it is listed on this report. Link to Representative Ortitay’s Opioid Reform Package Memorandum.

 

HB 2431 | 2017-2018 Session | Stephens, Todd (R) | Opioid Treatment Agreements
Summary: HB 2431 would amend Title 35 (Health and Safety), by adding a chapter (52B) related to opioid treatment agreements. Referred to House Health Committee on May 23, 2018. Prescriber is defined in HB 2431 as the follows: An individual who is licensed, registered or otherwise authorized to distribute, dispense or administer a controlled substance or prescription drug or device in the course of professional practice or research in this Commonwealth. The term shall not include a veterinarian. The “treatment agreement” is defined in HB 2431 as: A document signed by a prescriber and individual that contains a statement to ensure that the individual understands: (1) Treatment responsibilities; (2) The conditions of medication use; (3) The conditions under which the treatment of the individual may be terminated; (4) The responsibilities of the prescriber. Referred to House Health Committee on May 23, 2018. Link to Representative Todd’s Ensuring Patients Understand the Risks of Opioid Addiction Memorandum.

Contact

© Pennsylvania Coalition of
Nurse Practitioners
2400 Ardmore Blvd
Suite 302 : Pittsburgh, PA 15221
P: (412) 243-6149
F: (412) 243-5160